Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-15

Clinical Trial Update: The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation [Phase 2, Phase 3]

View source ↗

Summary

The document reports on the efficacy and proposed mechanism by which botulinum toxin may reduce scar formation after breast reduction surgery, based on Phase 2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Henry Ford Health System | Conditions: Scar, Hypertrophic Scar | Phase 2, Phase 3 | Status: COMPLETED